academic article

• High incidence of Philadelphia chromosome-like acute lymphoblastic leukemia in older adults with B-ALL..  Leukemia.  :-. 2017
• Potent efficacy of combined PI3K/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemia..  Blood.  129:177-187. 2017
• Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. 2014
• Aberrant STAT5 and PI3K/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemia..  Blood.  120:833-842. 2012
• Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study..  Blood.  119:3512-3522. 2012
• Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia..  Blood.  120:3510-3518. 2012
• JAK mutations in high-risk childhood acute lymphoblastic leukemia..  Proceedings of the National Academy of Sciences of the United States of America.  106:9414-9418. 2009